Funding

Protuoso Biosciences

United States · Biotech · AI · Enterprise software

Develops AI-enabled multifunctional biologics platform targeting cardiometabolic, oncology, and autoimmune diseases

Visit protuoso.bioFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed$9.5MDarwin Ventures — Role not disclosedNSG Ventures — Role not disclosedSEEDS — Role not disclosedTaya Venture — Role not disclosed

Investors

Darwin VenturesSeedNSG VenturesSeedSEEDSSeedTaya VentureSeed

Coverage

May 27, 2026Protuoso Biosciences · Seed

Similar companies

Fairy DevicesTokyo company developing wearable devices and remote-assistance software for industrial field workers.Undisclosed · JICN equity investment
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Sourcesprotuoso.bio ↗